Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 43461/0101.
Meloxicam 7.5 mg and 15 mg Tablets
Meloxicam 7.5 mg and 15 mg Tablets
meloxicam
1. What Meloxicam Tablet is and what it is used for
2. What you need to know before you take Meloxicam Tablets
3. How to take Meloxicam Tablets
4. Possible side effects
5. How to store Meloxicam Tablets
6. Contents of the pack and other information
The name of your medicine is Meloxicam 7.5 mg and 15 mg Tablets (referred to as Meloxicam Tablets in this leaflet).
Meloxicam Tablet contains the active substance meloxicam which belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs), which are used to reduce inflammation and pain in the joints and muscles.
Meloxicam Tablets are indicated for adults and children aged 16 years and over.
If you are unsure whether any of the above apply to you, please contact your doctor.
Talk to your doctor or pharmacist before taking Meloxicam
Warnings
Medicines such as Meloxicam Tablets may be associated with a small increased risk of heart attack (myocardial infarction) or stroke (apoplexy). Any risk is more likely with high doses and prolonged treatment.
Do not exceed the recommended doses or the duration of treatment (see section 3 “How to take Meloxicam Tablets”).
If you have heart problems, previous stroke or think that you might be at risk of these conditions, you should discuss your treatment with your doctor or pharmacist.
For example if you:
Stop your treatment with Meloxicam Tablets immediately as soon as you notice bleeding (causing black stools) or ulceration of your digestive tract (causing abdominal pain).
Potentially life-threatening skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported with the use of meloxicam, appearing initially as reddish target-like spots or circular patches often with central blisters on the trunk. Additional signs to look for include ulcers in the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes).
These potentially life-threatening skin rashes are often accompanied by flu-like symptoms. The rash may progress to widespread blistering or peeling of the skin.
The highest risk for occurrence of serious skin reactions is within the first weeks of treatment.
If you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of meloxicam, you must not be re-started on meloxicam at any time.
If you develop a rash or these skin symptoms, stop taking meloxicam, seek urgent advice from a doctor and tell him that you are taking this medicine.
Meloxicam Tablets are not appropriate if you require immediate relief from acute pain.
Meloxicam Tablets may hide the symptoms of infection (e.g. fever).
If you think you may have an infection you should see your doctor.
If you have ever developed fixed drug eruption (round or oval patches of redness and swelling of the skin that usually recurs at the same site(s), blistering, hives and itching) after taking meloxicam or other oxicams (e.g. piroxicam).
Precautions for use
As it will be necessary to adjust the treatment, it is important to ask your doctor's advice before you take Meloxicam Tablets in case of:
Your doctor will need to monitor your progress whilst on treatment.
Meloxicam Tablets are not for use in children and adolescents under 16 years of age.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including any medicines obtained without a prescription.
This is especially important if you are taking any of the following:
Tell the doctor if you are due to have a liver or kidney function test. This is important because taking meloxicam can affect the results.
Meloxicam Tablets should be swallowed whole with water, or another drink, during a meal.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
During the first and second trimester of pregnancy, your doctor may prescribe this medicine only if it is essential because it presents a potential risk of miscarriage and malformation. In this case, the dose should be as low as possible, and the duration of treatment as short as possible.
During the last three months of pregnancy, do not use this product, because Meloxicam Tablets can have serious effects on your foetus/child, in particular effects on his heart, lungs and/or kidneys, even with only one administration.
If you have taken this medicine during your pregnancy, you must immediately inform your doctor/midwife so that appropriate monitoring can be considered.
Breast-feeding
This product is not recommended during breast feeding.
Fertility
Meloxicam Tablets may make it more difficult to become pregnant. You should inform your doctor if you are planning to become pregnant or if you have problems becoming pregnant.
Do not drive or operate machines until you know how the tablets affect you. They may make you feel light headed, dizzy or drowsy, and may cause blurred vision. If they affect you in any way do not drive or operate machinery.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicinal product contains less than 1 mmol sodium (23 mg) per tablet, i.e. that it is essentially "sodium-free".
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or the pharmacist if you are not sure.
Attacks of osteoarthritis:
The recommended dose is 7.5 mg a day. Your doctor may increase your dose to 15 mg a day if necessary.
Rheumatoid arthritis and ankylosing spondylitis:
The recommended dose is 15 mg a day. Your doctor may reduce your dose to 7.5 mg a day if necessary.
Elderly patients and patients with increased risk of side effects:
The recommended dose for treatment of rheumatoid arthritis and ankylosing spondylitis in these patients is 7.5 mg a day.
Patients at increased risk of adverse effects
If you are a patient at increased risk of side effects, your doctor will start your treatment with 7.5 mg daily.
Do not exceed the recommended maximum dose of 15 mg a day.
If any of the statements listed under the heading "Warnings and precautions" apply to you, your doctor may restrict your dose to 7.5 mg (one tablet) once a day.
Patients with kidney impairment:
The maximum recommended dose for treatment in dialysis patients with severe kidney failure is 7.5 mg a day. No dose reduction is necessary in patients with mild to moderate renal impairment.
Hepatic insufficiency
No dose reduction is necessary in patients with mild to moderate hepatic impairment.
Meloxicam Tablets should not be taken by children and adolescents under 16 years of age.
If you feel that the effect of Meloxicam Tablets is too strong or too weak, or if after several days you do not feel any improvement in your condition you should talk to your doctor.
Meloxicam Tablets should be taken by mouth, with a drink of water or other liquid and with food. If you need to take two tablets (7.5mg) they must be taken together as a single dose. The score line is not intended for breaking the tablets.
If you realize you have taken more Meloxicam Tablets than your doctor has recommended (or if someone else has taken some of your Meloxicam Tablets), contact your doctor right away. If you cannot reach your doctor, go to the nearest hospital and take the pack with you.
Symptoms following acute NSAID overdose are usually limited to:
These symptoms generally get better when you stop taking Meloxicam Tablets. You may suffer from bleeding of the stomach or intestines (gastrointestinal bleeding).
Severe poisoning may result in a serious drug reaction (see section 4.):
If you forget to take a dose, take it as soon as you remember, unless it is nearly time for your next dose. Do not take a double dose to make up for the forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects although not everybody gets them.
Stop taking Meloxicam Tablets and consult a doctor or your nearest hospital immediately if you notice:
Erythema multiforme is a severe allergic reaction of the skin, causing spots, red or purple marks, or bubbles on the surface of the skin. This reaction can also affect the mouth, eyes and other mucous membranes
Bleeding from the digestive tract (gastrointestinal bleeding), formation of ulcers or the appearance of a perforation in the digestive tract can sometimes be severe and potentially fatal, especially in the elderly.
Tell your doctor immediately if you have previously suffered from such digestive tract symptoms as a result of prolonged use of anti-inflammatory drugs (NSAIDs), especially if you are elderly. Your doctor may need to monitor any changes in your condition during treatment.
If you have vision problems, do not drive or use machinery.
General side effects of nonsteroidal anti-inflammatory drugs (NSAIDs)
The use of certain non-steroidal anti-inflammatory drugs (NSAIDs) may be accompanied, particularly with high doses and in the event of long-term treatment, by a slightly increased risk of occlusion of arterial vessels (arterial thrombotic events ), which can cause a heart attack (myocardial infarction) or stroke (apoplexy).
Fluid retention (oedema), increased blood pressure (hypertension) and heart failure have been observed in association with NSAID treatment.
The most commonly observed side effects affect the digestive tract (gastrointestinal events):
The following side effects have been reported after administration of NSAIDs:
Less commonly, inflammation of the stomach (gastritis) has been observed
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1000 people)
These side effects can lead to an increased risk of infections, as well as symptoms such as bruising or nosebleeds.
Very rare: may affect up to 1 in 10,000 people
Erythema multiforme is a severe allergic reaction of the skin, causing spots, red or purple marks, or bubbles on the surface of the skin. This reaction can also affect the mouth, eyes and other mucous membranes.
inflammation of the liver (hepatitis). This can cause the following symptoms:
Not known: frequency cannot be estimated from the available data
Changes to the kidney structure resulting in acute kidney failure:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date printed on the carton and the blister after EXP. The expiry date refers to the last day of that month.
Do not store above 25°C. Store in the original package.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Each Meloxicam Tablet contains 7.5 mg or 15 mg of the active ingredient meloxicam.
The other ingredients are maize starch, pregelatinised starch, anhydrous colloidal silica, sodium citrate, lactose monohydrate, microcrystalline cellulose and magnesium stearate.
Meloxicam 7.5mg and 15mg Tablets are yellow, round, flat, uncoated tablets with bevelled edges. They are scored on one side and plain on the other side.
They are available in blister packs containing 10, 30 or 100 tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder
Manufacturer
Product licence number
PL 43461/0101
PL 43461/0102
The Leaflet was last revised in July 2023
POM
MPLLMELXXXXTBCOM
FPLXXX266V03